Paclitaxel protein-bound Interactions
There are 521 drugs known to interact with paclitaxel protein-bound, along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 443 are moderate, and 18 are minor.
- View all 521 medications that may interact with paclitaxel protein-bound
- View paclitaxel protein-bound alcohol/food interactions (1)
- View paclitaxel protein-bound disease interactions (4)
Most frequently checked interactions
View interaction reports for paclitaxel protein-bound and the medicines listed below.
- Actonel (risedronate)
- Actonel (risedronate)
- Advair Diskus (fluticasone / salmeterol)
- Advair Diskus (fluticasone / salmeterol)
- Ambien (zolpidem)
- Ambien (zolpidem)
- Calcium 600 D (calcium / vitamin d)
- Calcium 600 D (calcium / vitamin d)
- Creon (pancrelipase)
- Creon (pancrelipase)
- Fentanyl Transdermal System (fentanyl)
- Fentanyl Transdermal System (fentanyl)
- Gemzar (gemcitabine)
- Gemzar (gemcitabine)
- Lorazepam Intensol (lorazepam)
- Lorazepam Intensol (lorazepam)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Pepcid (famotidine)
- Pepcid (famotidine)
- Singulair (montelukast)
- Singulair (montelukast)
- Valproate Sodium (valproic acid)
- Valproate Sodium (valproic acid)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B Complex 100 (multivitamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Paclitaxel protein-bound alcohol/food interactions
There is 1 alcohol/food interaction with paclitaxel protein-bound.
Paclitaxel protein-bound disease interactions
There are 4 disease interactions with paclitaxel protein-bound which include:
Report options
More about paclitaxel protein-bound
- paclitaxel protein-bound consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.